Terms: = Bone cancer AND NCOA1, RIP160, 8648, ENSG00000084676, NCoA-1, SRC1, MGC129719, MGC129720, F-SRC-1 AND Treatment
3 results:
1. Immunohistochemical localization of steroid receptor coactivators in chondrosarcoma: an in vivo tissue microarray study.
Li W; Fu J; Bian C; Zhang J; Xie Z
Pathol Res Pract; 2014 Dec; 210(12):1005-10. PubMed ID: 24875297
[TBL] [Abstract] [Full Text] [Related]
2. A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.
Hartmaier RJ; Richter AS; Gillihan RM; Sallit JZ; McGuire SE; Wang J; Lee AV; Osborne CK; O'Malley BW; Brown PH; Xu J; Skaar TC; Philips S; Rae JM; Azzouz F; Li L; Hayden J; Henry NL; Nguyen AT; Stearns V; Hayes DF; Flockhart DA; Oesterreich S
Mol Endocrinol; 2012 Feb; 26(2):220-7. PubMed ID: 22174377
[TBL] [Abstract] [Full Text] [Related]
3. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancer.
Azuma H; Kotake Y; Yamamoto K; Sakamoto T; Kiyama S; Ubai T; Inamoto T; Takahara K; Matsuki M; Segawa N; Shibahara N; Katsuoka Y
Am J Clin Oncol; 2008 Feb; 31(1):11-21. PubMed ID: 18376222
[TBL] [Abstract] [Full Text] [Related]
